Thomas was Chairman of the Board at Arovella Therapeutics, and Executive Director at Neurotech International. Thomas Duthy joined OncoSil Medical in 2025.
Thomas Duthy is currently
Create your alert
to follow the career of Thomas Duthy.
Thomas Duthy has a PhD in Molecular Microbiology from University of Adelaide in 2000 and a Master of Business Administration from Deakin University in 2004.
They have also studied at University of Adelaide :
Find more alumni from University of Adelaide
They have also studied at Deakin University :
Find more alumni from Deakin University
Do you need to know more about Thomas Duthy? More results.
Report an error
Update the org chart details of Thomas Duthy.
Here are a few tips for establishing great contacts.
Discover the organization charts of your favorite companies.
Spot the influential executives using our search tools.
Receive notifications when executive positions change.